PH25993A - Cloning of DNA for protozoal antigens - Google Patents

Cloning of DNA for protozoal antigens Download PDF

Info

Publication number: PH25993A
Authority: PH; Philippines
Prior art keywords: protein; falciparum; sequence; nucleotide; fragment
Prior art date: 1984-02-22

Application number

PH31892A

Other languages

English (en)

Inventor

Anthony Arthur Holder

Michael James Lockyer

Jasbir Singh Sandhu

Valentina Riveros-Moreno

Gerrit Odink

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-02-22

Filing date

1985-02-21

Publication date

1992-01-13

1984-02-22 Priority claimed from GB848404692A external-priority patent/GB8404692D0/en

1984-09-26 Priority claimed from GB848424340A external-priority patent/GB8424340D0/en

1985-02-21 Application filed by Wellcome Found filed Critical Wellcome Found

1992-01-13 Publication of PH25993A publication Critical patent/PH25993A/en

Links

108091007433 antigens Proteins 0.000 title description 17
102000036639 antigens Human genes 0.000 title description 17
239000000427 antigen Substances 0.000 title description 15
238000010367 cloning Methods 0.000 title description 9
239000012634 fragment Substances 0.000 claims description 142
108090000623 proteins and genes Proteins 0.000 claims description 113
108020004414 DNA Proteins 0.000 claims description 105
102000004169 proteins and genes Human genes 0.000 claims description 95
239000002773 nucleotide Substances 0.000 claims description 51
125000003729 nucleotide group Chemical group 0.000 claims description 49
108090000765 processed proteins & peptides Proteins 0.000 claims description 47
102000004196 processed proteins & peptides Human genes 0.000 claims description 36
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 33
239000013598 vector Substances 0.000 claims description 33
108091028043 Nucleic acid sequence Proteins 0.000 claims description 32
108091026890 Coding region Proteins 0.000 claims description 27
229920001184 polypeptide Polymers 0.000 claims description 25
241000223960 Plasmodium falciparum Species 0.000 claims description 19
229960005486 vaccine Drugs 0.000 claims description 16
230000036039 immunity Effects 0.000 claims description 14
201000004792 malaria Diseases 0.000 claims description 10
230000001939 inductive effect Effects 0.000 claims description 7
229940070376 protein Drugs 0.000 claims description 6
241001044169 Parum Species 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 2
230000000875 corresponding effect Effects 0.000 claims 36
235000012571 Ficus glomerata Nutrition 0.000 claims 1
240000000365 Ficus racemosa Species 0.000 claims 1
235000015125 Sterculia urens Nutrition 0.000 claims 1
239000003937 drug carrier Substances 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 55
108020001507 fusion proteins Proteins 0.000 description 44
102000037865 fusion proteins Human genes 0.000 description 42
238000000034 method Methods 0.000 description 23
239000000523 sample Substances 0.000 description 20
239000013612 plasmid Substances 0.000 description 19
210000004027 cell Anatomy 0.000 description 18
150000001413 amino acids Chemical class 0.000 description 15
239000000047 product Substances 0.000 description 14
239000002299 complementary DNA Substances 0.000 description 13
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 12
241000283973 Oryctolagus cuniculus Species 0.000 description 12
210000003936 merozoite Anatomy 0.000 description 11
108091008146 restriction endonucleases Proteins 0.000 description 11
210000002966 serum Anatomy 0.000 description 11
235000001014 amino acid Nutrition 0.000 description 10
229960000723 ampicillin Drugs 0.000 description 9
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
239000000499 gel Substances 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000007983 Tris buffer Substances 0.000 description 8
230000000890 antigenic effect Effects 0.000 description 8
239000000284 extract Substances 0.000 description 8
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 8
WLNBMPZUVDTASE-HXIISURNSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;sulfuric acid Chemical compound [O-]S([O-])(=O)=O.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO.O=C[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO WLNBMPZUVDTASE-HXIISURNSA-N 0.000 description 7
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 7
101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 description 7
239000002253 acid Substances 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
230000004927 fusion Effects 0.000 description 7
210000001563 schizont Anatomy 0.000 description 7
241000894007 species Species 0.000 description 7
101150044170 trpE gene Proteins 0.000 description 7
108020004705 Codon Proteins 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
238000010276 construction Methods 0.000 description 6
230000029087 digestion Effects 0.000 description 6
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
238000003780 insertion Methods 0.000 description 6
230000037431 insertion Effects 0.000 description 6
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
230000007017 scission Effects 0.000 description 6
238000001262 western blot Methods 0.000 description 6
108091081024 Start codon Proteins 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
230000002163 immunogen Effects 0.000 description 5
239000000463 material Substances 0.000 description 5
244000045947 parasite Species 0.000 description 5
238000012545 processing Methods 0.000 description 5
230000009466 transformation Effects 0.000 description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
241000224016 Plasmodium Species 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
239000000872 buffer Substances 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
210000005056 cell body Anatomy 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 4
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
229940079938 nitrocellulose Drugs 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
238000011282 treatment Methods 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
108010076504 Protein Sorting Signals Proteins 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
229960003964 deoxycholic acid Drugs 0.000 description 3
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
229920001220 nitrocellulos Polymers 0.000 description 3
-1 nucleoside triphosphate Chemical class 0.000 description 3
239000008188 pellet Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
235000019333 sodium laurylsulphate Nutrition 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000010186 staining Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000013519 translation Methods 0.000 description 3
230000014616 translation Effects 0.000 description 3
239000001226 triphosphate Substances 0.000 description 3
235000011178 triphosphate Nutrition 0.000 description 3
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
241000950314 Figura Species 0.000 description 2
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
238000000636 Northern blotting Methods 0.000 description 2
244000046052 Phaseolus vulgaris Species 0.000 description 2
235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
241000223830 Plasmodium yoelii Species 0.000 description 2
101100439111 Rattus norvegicus Cebpd gene Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
239000008272 agar Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000001976 enzyme digestion Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
208000023414 familial retinal arterial macroaneurysm Diseases 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
230000028993 immune response Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
239000006166 lysate Substances 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000013507 mapping Methods 0.000 description 2
239000012528 membrane Substances 0.000 description 2
239000002777 nucleoside Substances 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
238000012163 sequencing technique Methods 0.000 description 2
230000001360 synchronised effect Effects 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
238000000844 transformation Methods 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
102100021503 ATP-binding cassette sub-family B member 6 Human genes 0.000 description 1
108010037870 Anthranilate Synthase Proteins 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
241000283725 Bos Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
101100135641 Caenorhabditis elegans par-3 gene Proteins 0.000 description 1
101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
241000710198 Foot-and-mouth disease virus Species 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
241001669573 Galeorhinus galeus Species 0.000 description 1
241000726221 Gemma Species 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
101000677883 Homo sapiens ATP-binding cassette sub-family B member 6 Proteins 0.000 description 1
101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 1
101001131829 Homo sapiens P protein Proteins 0.000 description 1
101000641419 Homo sapiens V-type proton ATPase 16 kDa proteolipid subunit c Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
102100034866 Kallikrein-6 Human genes 0.000 description 1
125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
102100038609 Lactoperoxidase Human genes 0.000 description 1
108010023244 Lactoperoxidase Proteins 0.000 description 1
DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000211181 Manta Species 0.000 description 1
JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
101100013496 Mus musculus Aifm2 gene Proteins 0.000 description 1
101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
101500006448 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) Endonuclease PI-MboI Proteins 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
241000224024 Plasmodium chabaudi Species 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
241000677647 Proba Species 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
229910019567 Re Re Inorganic materials 0.000 description 1
208000037656 Respiratory Sounds Diseases 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000282695 Saimiri Species 0.000 description 1
241000252141 Semionotiformes Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241001302210 Sida <water flea> Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
241000767684 Thoe Species 0.000 description 1
IYHNBRUWVBIVJR-IHRRRGAJSA-N Tyr-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IYHNBRUWVBIVJR-IHRRRGAJSA-N 0.000 description 1
102100034171 V-type proton ATPase 16 kDa proteolipid subunit c Human genes 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
241001672648 Vieira Species 0.000 description 1
ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
244000309466 calf Species 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
229940000425 combination drug Drugs 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
239000006167 equilibration buffer Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
102000047119 human OCA2 Human genes 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
229940057428 lactoperoxidase Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000012160 loading buffer Substances 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
NFGXHKASABOEEW-LDRANXPESA-N methoprene Chemical compound COC(C)(C)CCCC(C)C\C=C\C(\C)=C\C(=O)OC(C)C NFGXHKASABOEEW-LDRANXPESA-N 0.000 description 1
239000000203 mixture Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000012510 peptide mapping method Methods 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000004224 protection Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
244000000040 protozoan parasite Species 0.000 description 1
206010037833 rales Diseases 0.000 description 1
238000002271 resection Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
235000011091 sodium acetates Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000037351 starvation Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000004448 titration Methods 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PH31892A 1984-02-22 1985-02-21 Cloning of DNA for protozoal antigens PH25993A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB848404692A GB8404692D0 (en)	1984-02-22	1984-02-22	Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en)	1984-09-26	1984-09-26	Cloning of dna

Publications (1)

Publication Number	Publication Date
PH25993A true PH25993A (en)	1992-01-13

Family

ID=26287348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH31892A PH25993A (en)	1984-02-22	1985-02-21	Cloning of DNA for protozoal antigens

Country Status (14)

Country	Link
US (1)	US5597708A (da)
EP (1)	EP0154454B1 (da)
JP (2)	JP2584733B2 (da)
AT (1)	ATE64957T1 (da)
AU (1)	AU592749B2 (da)
CA (1)	CA1340103C (da)
DE (1)	DE3583347D1 (da)
DK (1)	DK79985A (da)
GB (1)	GB2154592A (da)
HU (1)	HU200794B (da)
IL (1)	IL74409A (da)
NZ (1)	NZ211191A (da)
PH (1)	PH25993A (da)
ZW (1)	ZW2485A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0153188B1 (en) *	1984-02-21	1991-10-09	National Research Development Corporation	Improvements in or relating to the production of malaria vaccines
IL76338A (en) *	1984-09-11	1994-08-26	Saramane Pty Ltd	Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
ZW8386A1 (en) *	1985-04-11	1986-07-23	Inst Medical W & E Hall	Highly repetitive antigens of plasmodium falciparum
US4978621A (en) *	1985-09-03	1990-12-18	Scripps Clinic And Research Foundation	Merozoite surface antigens
EP0252098A4 (en) *	1985-12-24	1989-11-29	Inst Medical W & E Hall	ANTIGENS IN THE ASEXUAL BLOOD PHASE OF -i (PLASMODIUM FALCIPARUM).
EP0252588A3 (en) *	1986-05-12	1989-07-12	Smithkline Beecham Corporation	Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US5001225A (en) *	1986-12-08	1991-03-19	Georgetown University	Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) *	1987-03-19	1987-04-23	Hoffmann La Roche	Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) *	1987-11-03	1989-05-18	Behringwerke Ag	Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) *	1987-11-13	1989-09-25	Wellcome Found	Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) *	1987-12-30	1989-07-13	Behringwerke Ag	Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en)	1988-08-12	2001-12-25	Joseph W. Inselburg	Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) *	1991-07-01	1998-05-26	Pasteur Merieux Serums Et Vaccins	Malaria recombinant poxvirus
US6855316B1 (en) *	1994-02-14	2005-02-15	University Of Hawaii	Baculovirus produced Plasmodium falciparum vaccine
FR2744723A1 (fr) *	1996-02-14	1997-08-14	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) *	1996-02-14	2002-08-02	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) *	1996-10-02	1998-05-14	Hermann Prof Dr Bujard	Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
MY140679A (en)	2001-05-24	2010-01-15	Avanir Pharmaceuticals	Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
US20040082048A1 (en) *	2002-10-15	2004-04-29	Viswanath Nittala Venkata Narasimha	Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) *	2003-02-14	2004-10-01	Avanir Pharmaceutics	Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
MXJL06000006A (es)	2003-08-22	2006-05-04	Avanir Pharmaceuticals	Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
JP2008534502A (ja)	2005-03-24	2008-08-28	アバニール・ファーマシューティカルズ	マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) *	2006-03-21	2006-05-03	Novartis Ag	Organic compounds
US7931908B2 (en) *	2007-02-23	2011-04-26	Philadelphia Health Education Corporation	Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4466917A (en) *	1981-02-12	1984-08-21	New York University	Malaria vaccine
GB2145092B (en) *	1983-01-28	1988-04-07	Univ New York	Protective peptide antigen
IL65496A (en) *	1981-04-15	1985-10-31	Wellcome Found	Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) *	1983-01-28	1988-02-18	Saramane Pty Ltd	Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) *	1983-08-19	1988-08-30	University Of Illinois	Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) *	1984-02-20	1984-03-28	Biogen Nv	Dna sequence recombinant dna molecules

1985
- 1985-02-21 AT AT85301173T patent/ATE64957T1/de not_active IP Right Cessation
- 1985-02-21 HU HU85648A patent/HU200794B/hu not_active IP Right Cessation
- 1985-02-21 DE DE8585301173T patent/DE3583347D1/de not_active Expired - Lifetime
- 1985-02-21 NZ NZ211191A patent/NZ211191A/en unknown
- 1985-02-21 DK DK79985A patent/DK79985A/da not_active Application Discontinuation
- 1985-02-21 ZW ZW24/85A patent/ZW2485A1/xx unknown
- 1985-02-21 IL IL7440985A patent/IL74409A/en not_active IP Right Cessation
- 1985-02-21 GB GB08504429A patent/GB2154592A/en not_active Withdrawn
- 1985-02-21 AU AU39046/85A patent/AU592749B2/en not_active Ceased
- 1985-02-21 PH PH31892A patent/PH25993A/en unknown
- 1985-02-21 EP EP85301173A patent/EP0154454B1/en not_active Expired - Lifetime
- 1985-02-21 CA CA000474837A patent/CA1340103C/en not_active Expired - Fee Related
- 1985-02-22 JP JP60034280A patent/JP2584733B2/ja not_active Expired - Lifetime
1993
- 1993-09-16 JP JP5230426A patent/JP2893626B2/ja not_active Expired - Lifetime
- 1993-12-02 US US08/160,158 patent/US5597708A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
GB2154592A (en)	1985-09-11
US5597708A (en)	1997-01-28
AU592749B2 (en)	1990-01-25
ZW2485A1 (en)	1986-09-24
JPS6119490A (ja)	1986-01-28
JP2584733B2 (ja)	1997-02-26
JPH06189772A (ja)	1994-07-12
DE3583347D1 (de)	1991-08-08
HUT37460A (en)	1985-12-28
GB8504429D0 (en)	1985-03-27
AU3904685A (en)	1985-09-05
EP0154454B1 (en)	1991-07-03
HU200794B (en)	1990-08-28
ATE64957T1 (de)	1991-07-15
IL74409A0 (en)	1985-05-31
DK79985D0 (da)	1985-02-21
NZ211191A (en)	1988-01-08
DK79985A (da)	1985-08-23
EP0154454A1 (en)	1985-09-11
IL74409A (en)	1994-08-26
CA1340103C (en)	1998-10-27
JP2893626B2 (ja)	1999-05-24

Publication	Publication Date	Title
PH25993A (en)	1992-01-13	Cloning of DNA for protozoal antigens
Saul et al.	1992	The 42-kilodalton rhoptry-associated protein of Plasmodium falciparum
AU694142B2 (en)	1998-07-16	Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
JP3215692B2 (ja)	2001-10-09	組み換えコクシジウム症ワクチン
US5403581A (en)	1995-04-04	Coccidiosis vaccines
US20050095256A1 (en)	2005-05-05	Recombinant process for preparing a complete malaria antigen gp190/MSP1
Mattei et al.	1988	The S-antigen of Plasmodium falciparum Palo Alto represents a new S-antigen serotype
WO1988002757A1 (en)	1988-04-21	Hybrid proteins or polypeptides
US5395614A (en)	1995-03-07	Protective Plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens HRPII and SERP, the preparation and use thereof
US5393523A (en)	1995-02-28	Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II
AU604711B2 (en)	1991-01-03	Novel vaccines
EP0541629B1 (en)	1998-12-23	Cloning and expression of a rhoptry associated protein of (p.falciparum)
AU645831B2 (en)	1994-01-27	Cloning and expression of a rhoptry associated protein of P.falciparum
IE910966A1 (en)	1991-09-25	Plasmodium Sporozoite Antigen
IE920541A1 (en)	1992-08-26	A plasmodium falciparum blood-stage antigen, the preparation¹and use thereof
AU8150687A (en)	1988-05-06	Hybrid proteins or polypeptides